Methotrexate at middle and high accumulative doses might be associated with lower risk of new-onset cancers in patients with rheumatoid arthritis: a nationwide population-based cohort study. (IF: 5.35; SCIE: Q1)
Methotrexate at middle and high accumulative doses might be associated with lower risk of new-onset cancers in patients with rheumatoid arthritis: a nationwide population-based cohort study. (IF: 5.35; SCIE: Q1)
Year | 2020 |
Author | 彭武村 |
Author count | 1 |
Created date | 2021-09-11 |
Author order | 第一作者 |
Corresponding author | 否 |
Publication year | 2020 |
Publication month | 12 |
Journal name | Therapeutic Advances in Musculoskeletal Disease (Ther Adv Musculoskelet Dis) |
Publication area | 美國 |
Volume | 12 |
Issue | 0 |
Start page | 1 |
End page | 12 |
Publication type | |
Review system | 是 |
Language | Foreign Language |